跳至主要内容
临床试验/CTIS2023-505357-40-00
CTIS2023-505357-40-00招募中1 期

A Single-Blind randomized trial of High-Dose versus Standard-Dose Inactivated Influenza Vaccine in Adult Patients Treated for an Hematological Cancer (Flu-Hemato-Rando study)

CHU De Liege0 个研究点目标入组 180 人开始时间: 2023年6月1日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
180

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 65+(—)
性别
All

入选标准

  • Patients under treatment for: a multiple myeloma, or a B-cell malignancy (including patients given rituximab in the 6 months prior to vaccine even if no additional treatment given)., or a myeloid malignancy (hydroxyurea or tyrosine kinase inhibitors are not be considered as a treatment” for the current study in contrast to JAK inhibitors or azacitidine) or standard chemotherapy, Age > or = 18 years at inclusion, Written informed consent

排除标准

  • HIV seropositivity, Pregnancy, Egg allergy or allergy to previous influenza vaccine, IVIg in the past 30 days or planning to receive IVIg in the 4 weeks after vaccination, Prior post-transplant IIV vaccination in the same season, Severe Heart failure (ejection fraction < 35%) at the last examination

研究者

发起方
CHU De Liege

相似试验

进行中(未招募)
1 期
An investigation to investigate whether a single dose of XEN-D0501 is tolerable by type 2 diabetic patients prior to multiple dose trials (to investigate if the compound can effectively regulate diabetes)Type 2 diabetes
EUCTR2016-003843-12-DKPILA PHARMA26
招募中
2 期
A randomised controlled study of high dose versus standard dose antibiotics for the prevention of bacterial sepsis in advanced liver diseaseOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonInfection - Studies of infection and infectious agentsbacterial infectioncirrhosis
ACTRN12609001076268Austin Health90
进行中(未招募)
不适用
A single injection study to investigate the safety and efficacy of a new drug (FX006) in patients with osteoarthritis of the knee.Osteoarthritis of the kneeMedDRA version: 17.1Level: LLTClassification code 10023476Term: Knee osteoarthritisSystem Organ Class: 100000004859
EUCTR2014-005329-11-LTFlexion Therapeutics450
进行中(未招募)
不适用
A single injection study to investigate the safety and efficacy of a new drug (FX006) in patients with osteoarthritis of the knee.Osteoarthritis of the kneeMedDRA version: 18.0Level: LLTClassification code 10023476Term: Knee osteoarthritisSystem Organ Class: 100000004859
EUCTR2014-005329-11-DKFlexion Therapeutics450
进行中(未招募)
不适用
A single injection study to investigate the safety and efficacy of a new drug (FX006) in patients with osteoarthritis of the knee.
EUCTR2014-005329-11-EEFlexion Therapeutics450